What is Complion?
Complion operates at the intersection of clinical research and enterprise software, providing a specialized eRegulatory platform designed to replace manual, error-prone documentation processes. Founded by a clinical researcher, the company addresses the specific pain points of site regulatory management, offering a purpose-built solution that facilitates remote monitoring and document compliance. By enabling seamless collaboration between research sites, sponsors, and CROs, Complion ensures that essential study documents are managed with high integrity and accessibility. Its software suite is engineered to support the rigorous demands of modern clinical trials, ranging from cancer centers to large-scale academic medical institutions, thereby reducing administrative overhead and enhancing the overall quality of site monitoring.
How much funding has Complion raised?
Complion has raised a total of $12.2M across 4 funding rounds:
Private Equity
$2M
Series A
$2.9M
Series B
$7M
Debt
$350K
Private Equity (2015): $2M, investors not publicly disclosed
Series A (2016): $2.9M, investors not publicly disclosed
Series B (2019): $7M supported by Beringea , LLC.
Debt (2020): $350K featuring PPP
Key Investors in Complion
Beringea, LLC.
Beringea is an international venture capital firm that invests in high-growth businesses in the US and UK, focusing on empowering entrepreneurs to build billion-dollar companies. Their expertise spans multiple sectors including healthcare, providing strategic support to guide companies through industry shifts.
Undisclosed Investors
PPP
Public-Private Partnership
What's next for Complion?
With this latest infusion of capital, Complion is well-positioned to accelerate its product development roadmap and expand its footprint within the global life sciences market. The strategic focus will likely center on enhancing its remote monitoring capabilities and deepening the integration of its software within the broader clinical trial ecosystem. As the industry shifts toward decentralized and hybrid trial models, Complion's ability to provide a centralized, compliant, and efficient regulatory environment will be a key differentiator. The company is expected to leverage these resources to further automate document workflows, thereby driving down costs for sponsors while maintaining the highest standards of regulatory compliance and data security in an increasingly complex research landscape.
See full Complion company page
